Cornercap Investment Counsel Inc Gritstone Bio, Inc. Transaction History

Cornercap Investment Counsel Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.19 - $2.26 $1,234 - $2,343	-1,037 Reduced 1.33%	76,811 $132,000
Q2 2023 Aug 11, 2023	BUY	$1.66 - $3.03 $1,331 - $2,430	802 Added 1.04%	77,848 $151,000
Q3 2022 Nov 14, 2022	BUY	$2.46 - $4.75 $47,623 - $91,955	19,359 Added 33.56%	77,046 $198,000
Q2 2022 Aug 15, 2022	BUY	$1.77 - $4.34 $102,105 - $250,361	57,687 New	57,687 $140,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.